All read papers (9)

Overlapping MHC class I/II Epitopes Program cDC1-like Differentiation of Monocyte-Derived Dendritic Cells via mTORC1 Signaling Inhibition

Amanya S, Murthy A, Bisht N, Bullock Z, Ernste K, Vasquez-Perez J, Liu W, Trivedi A, Oyewole-Said D, Paul A, Umokoro L, Akhanov V, Samuel M, Shi Z, Nguyen M, Huang S, Jeong M, Iakova P, Jain K, Pham K, Kraushaar D, Konduri V, Decker W.

Preprint · 2026

3.0/5

Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells

Kirkling ME, Cytlak U, Lau CM, Lewis KL, Resteu A, Khodadadi-Jamayran A, Siebel CW, Salmon H, Merad M, Tsirigos A, Collin M, Bigley V, Reizis B.

2018

Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications

Balan S, O'Brien L, Peros A, Wang X, Leal Rojas I, McClain C, Radford KJ, Bhardwaj N.

2025

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors

Singh MM, Manton CA, Bhat KP, Tsai WW, Aldape K, Barton MC, Chandra J.

2011

RAS(ON) Therapies on the Horizon to Address KRAS Resistance: Highlight on a Phase III Clinical Candidate Daraxonrasib (RMC-6236)

Ma Z, Zhou M, Shen Q, Zhou J.

2025

Differential assembly of mouse and human tumor microenvironments

Courau T, Jaszczak RG, Samad B, Flynn E, Chew NW, Reeder GC, Tsui J, Teklu S, Pass LF, Edwards AW, Naser M, Ray A, Wismer H, Bunis D, Lupin-Jimenez L, Gavil NV, Masopust D, Graham JP, Skelly DA, Vesco X, Liu ET, Fragiadakis GK, Combes AJ, Krummel MF.

2026

3.3/5